Action details
Memorandum of Understanding
CSO Approval date
Start of Action
End of Action
Research Outputs
Updates on the research outputs of CliniMARK are provided on this page.
International peer-reviewed journal articles
CliniMARK working papers
Related publications
Management Committee & Working Group Leaders
News & Events
2ND CONFERENCE VALIDATION OF BIOMARKERS
On 28 March 2019 the 2nd conference Validation of Biomarkers took place in Basel, Switzerland. Please follow the link to find the presentations.
Handbook of Biomarkers and Precision Medicine.
"Handbook of Biomarkers and Precision Medicine" provides comprehensive insights into biomarker discovery and development which has driven the new era of Precision Medicine. A wide variety of renowned experts from government, academia, teaching hospitals, biotechnology and pharmaceutical companies share best practices, examples and exciting new developments.
Edited by Carini C, Fidock MD and van Gool AJ
Edited by Carini C, Fidock MD and van Gool AJ
COST CliniMARK Training School September 23rd - 27th 2019, Athens - Greece
The unique feature of the proposed workshop is that it will expose the problems associated with omics biomarker studies and train a new generation of scientists able to fix the flawed biomarker discovery and implementation paradigm.
Other consortia on biomarker: X-omics.nl and BIC
The Netherlands X-omics Initiative is a new facility as part of the National Roadmap for Large-Scale Research Infrastructures. It is partly funded by NWO with a total budget of 40 million euro. The project started on September 2018 and will last for ten years.
Biomarker Commercialization BIC. A consortium to assist biomarkers reach their full potential.
Biomarker Commercialization BIC. A consortium to assist biomarkers reach their full potential.
TMX Winter School 2019 November 11th - 15th, Barcelona - Spain
The TMex winter school 2019 builds on the experience of the C-COMEND and ENLIGHT-TEN courses on translational research and medicine development which in 2016, 2017 & 2018 delivered three highly valued courses.
Bridging the translational innovation gap through good biomarker practice
In collaboration with the European technology infrastructures EATRIS, BBMRI and ELIXIR, prof van Gool and other scientists from the Biomarker Development Center published a comment in Nature Reviews Drug Discovery to join efforts in defining the Good Biomarker Principle guidelines that will support successful biomarker discovery and development activities. These guidelines will be defined in the COST action CliniMARK, initiated and coordinated by dr Luider of the BDC. See comment here.
CliniMARK Kick-off meeting
The CliniMARK network has the goal of establishing "Best Biomarker Practice" (BBP) guidelines to radically improve the process from biomarker discovery to clinical use. The kick-off meeting was held at the COST offices in Brussels on March 14, 2017. A plan was developed to define BBP guidelines and to apply these guidelines for the validation of biomarkers with COPD as an example. The next meeting will be held from October 5 to 7, 2017, at the Erasmus MC (Rotterdam) in conjunction with the Biomarker Symposium. For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it..
